Company profile: Genova Diagnostics
1.1 - Company Overview
Company description
- Provider of global specialty clinical laboratory testing using a systems approach to support personalized treatment and prevention of chronic disease. Offers diagnostic profiles including GI Effects stool analysis; NutrEval; Metabolomix+ urine-based nutritional biomarkers (optional bloodspot, buccal swab); Methylation Panel (plasma metabolites, genetic SNPs); Endo+ hormone assessment; and Adrenocortex Stress Profile of the HPA axis.
Products and services
- GI Effects Comprehensive Stool Profile: Delivers clinical-grade stool analysis that evaluates digestive function, assesses intestinal inflammation, and characterizes the intestinal microbiome for comprehensive gastrointestinal profiling
- Metabolomix+: Engineers a non-invasive first-morning void urine-based panel that analyzes key nutritional biomarkers, with optional add-on bloodspot finger stick and buccal swab for expanded profiling
- NutrEval: Produces a clinical-grade assessment quantifying needs for antioxidants, vitamins, minerals, amino acids, and fatty acids, and evaluates toxic exposures
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genova Diagnostics
SpliceBio
HQ: Spain
Website
- Description: Provider of genetic medicines using a proprietary Protein Splicing platform to develop gene therapies for genetic diseases, enabling delivery of large genes that cannot be packaged into single AAV vectors. Programs include a Stargardt disease therapy targeting ABCA4 and gene therapy initiatives in other therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SpliceBio company profile →
ADARx Pharmaceuticals
HQ: United States
Website
- Description: Provider of genetic medicine technologies focused on the base editing of mRNA transcripts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADARx Pharmaceuticals company profile →
Decode Genetics
HQ: Iceland
Website
- Description: Provider of biopharmaceutical diagnostic tests for gene variant detection, using population studies to identify human genes linked to common diseases and applying findings to guide candidate drug development; has discovered key genetic risk factors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decode Genetics company profile →
GeneTether
HQ: United States
Website
- Description: Provider of genome editing enhancement platforms that tether or conjugate donor DNA templates to editing complexes, including the GeneTether Platform and TNT technology to boost DNA insertion efficiency with targeted tools like CRISPR-Cas, and pursuing strategic partnerships in human therapeutics, animal health, agriculture, and cell delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneTether company profile →
Treos Bio
HQ: United Kingdom
Website
- Description: Provider of computational immunology solutions that predict in silico likely responders to cancer immunotherapies and design next-generation targeted immunotherapies tailored to patient genetics; offers PolyPEPI1018 for metastatic colorectal cancer (developed without need for tumor biopsy), PEPI Panel to create personalized therapies based on tumor type and HLA genotype, PolyPEPI-SCoV-2 preventive vaccine, and PEPI Test predicting peptide-specific T cell responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Treos Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genova Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genova Diagnostics
2.2 - Growth funds investing in similar companies to Genova Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genova Diagnostics
4.2 - Public trading comparable groups for Genova Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →